{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:13:34Z","timestamp":1789373614994,"version":"build-2803163510"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T00:00:00Z","timestamp":1431907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0127058","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T19:45:50Z","timestamp":1431978350000},"page":"e0127058","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Lotte M.E.","family":"Berghauser Pont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenneke J.","family":"Kloezeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna K.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"de Vrij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieger","family":"Leenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens M.F.","family":"Dirven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine L.M.","family":"Lamfers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,18]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"R Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"ref2","doi-asserted-by":"crossref","first-page":"iii39","DOI":"10.1093\/neuonc\/nou208.61","article-title":"First-in-human phase I clinical trial of oncolytic delta-24-rgd (dnx-2401) with biological endpoints: implications for viro- immunotherapy","volume":"16","author":"FF Lang","year":"2014","journal-title":"Neuro Oncol"},{"issue":"20","key":"ref3","first-page":"5736","article-title":"Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy","volume":"62","author":"ML Lamfers","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02913307","article-title":"Apoptosis in health and disease and modulation of apoptosis for therapy: An overview","volume":"22","author":"N Singh","year":"2007","journal-title":"Indian journal of clinical biochemistry: IJCB"},{"issue":"22","key":"ref5","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1128\/JVI.78.22.12243-12251.2004","article-title":"Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death","volume":"78","author":"MA Abou El Hassan","year":"2004","journal-title":"J Virol"},{"issue":"18","key":"ref6","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/jnci\/djm102","article-title":"Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death","volume":"99","author":"H Jiang","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"ref7","first-page":"2953","article-title":"Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells","volume":"61","author":"TP Cripe","year":"2001","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"ref8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jgm.2703","article-title":"Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma","volume":"15","author":"J de Jonge","year":"2013","journal-title":"J Gene Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-394387-3.00006-9","article-title":"Histone deacetylase inhibitors and rational combination therapies","volume":"116","author":"S Grant","year":"2012","journal-title":"Advances in cancer research"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/CAD.0b013e328012a5db","article-title":"Histone deacetylase inhibitors for epigenetic therapy of cancer","volume":"18","author":"C Monneret","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"17","key":"ref11","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1073\/pnas.1204429109","article-title":"Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death","volume":"109","author":"N Gammoh","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref12","first-page":"218","article-title":"Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors","volume":"29","author":"DR Kim","year":"2012","journal-title":"Int J Mol Med"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines","volume":"9","author":"J Lee","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"ref14","first-page":"120","article-title":"A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency","volume":"7","author":"K Suzuki","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nbt0697-542","article-title":"Alpha v integrins as receptors for tumor targeting by circulating ligands","volume":"15","author":"R Pasqualini","year":"1997","journal-title":"Nature biotechnology"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.3390\/v6083080","article-title":"Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma","volume":"6","author":"RK Balvers","year":"2014","journal-title":"Viruses"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/neuonc\/not116","article-title":"Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules","volume":"15","author":"RK Balvers","year":"2013","journal-title":"Neuro Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Advances in enzyme regulation"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"RG Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"ref20","article-title":"DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells","author":"LM Berghauser Pont","year":"2014","journal-title":"Cancer Lett"},{"issue":"11\u201312","key":"ref21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.18632\/genesandcancer.42","article-title":"The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells","volume":"5","author":"LM Berghauser Pont","year":"2014","journal-title":"Genes Cancer"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"RG Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"TC Chou","year":"2010","journal-title":"Cancer Res"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/mt.2008.155","article-title":"Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses","volume":"16","author":"A Otsuki","year":"2008","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/1535-7163.MCT-07-0395","article-title":"Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models","volume":"7","author":"Y Sasaki","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1535-7163.MCT-06-0431","article-title":"The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems","volume":"6","author":"ME Goldsmith","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"e14462","DOI":"10.1371\/journal.pone.0014462","article-title":"Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors","volume":"5","author":"H MacTavish","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ymthe.2006.07.009","article-title":"Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy","volume":"14","author":"N Hoti","year":"2006","journal-title":"Mol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-11-375","article-title":"Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis","volume":"11","author":"S Wedel","year":"2011","journal-title":"BMC Cancer"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3892\/ijmm.2012.1133","article-title":"Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer","volume":"30","author":"J Ma","year":"2012","journal-title":"Int J Mol Med"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.cgt.7700726","article-title":"Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells","volume":"11","author":"MD Sachs","year":"2004","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1194\/jlr.M031450","article-title":"Regulation of integrin alphaV subunit expression by sulfatide in hepatocellular carcinoma cells","volume":"54","author":"W Wu","year":"2013","journal-title":"J Lipid Res"},{"issue":"52","key":"ref33","doi-asserted-by":"crossref","first-page":"41062","DOI":"10.1074\/jbc.M110.184481","article-title":"A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors","volume":"285","author":"E Simboeck","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.mt.6300400","article-title":"Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death","volume":"16","author":"MM Alonso","year":"2008","journal-title":"Mol Ther"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10495-008-0303-9","article-title":"Immunogenic cell death modalities and their impact on cancer treatment","volume":"14","author":"O Kepp","year":"2009","journal-title":"Apoptosis"},{"issue":"47","key":"ref36","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/onc.2013.482","article-title":"The role of p21(waf1\/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Emu-myc model of B-cell lymphoma","volume":"33","author":"A Newbold","year":"2014","journal-title":"Oncogene"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"e97495","DOI":"10.1371\/journal.pone.0097495","article-title":"The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity","volume":"9","author":"A Kleijn","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"e97407","DOI":"10.1371\/journal.pone.0097407","article-title":"Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model","volume":"9","author":"H Jiang","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2174\/138920112800958913","article-title":"Oncolytic viruses for induction of anti-tumor immunity","volume":"13","author":"AW Tong","year":"2012","journal-title":"Current pharmaceutical biotechnology"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/icb.2011.96","article-title":"Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer","volume":"90","author":"KV Woan","year":"2012","journal-title":"Immunol Cell Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0127058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T09:45:22Z","timestamp":1599039922000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0127058"}},"subtitle":[],"editor":[{"given":"Marta M.","family":"Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,18]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0127058","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,18]]}}}